Fulcrum Therapeutics Inc
FULC
$3.77+0.53%
End of day · as of Oct 12, 2026, 2:02 AM ET
Mkt cap
$426.98M
EV/Sales
N/A
P/E ratio
N/A
FY2025 Revenue
N/A
EPS (H1 2026)
$-0.59
Gross Margin (FY2025)
N/A
Profit Margin (FY2025)
N/A
Beta
2.42
Div yield
N/A
Sector
Healthcare
Fulcrum Therapeutics Inc (FULC) is a biotechnology company listed on US.
Latest reported FULC revenue for 2025-12-31 was $0. Net income was -$74.9M. Revenue was down 100.0% from 2024-12-31 to 2025-12-31. FULC currently screens at market cap $427.0M.
Use this FULC research hub for sector, financials, and filings — not a live tape.
Latest cached year on this hub. Full FULC income, balance, and cash tables.
Fulcrum Therapeutics Inc (FULC) is a biotechnology company in the Healthcare sector.
Latest cached Fulcrum Therapeutics Inc (FULC) net income for Dec 31, 2025 was -$74.9M. Statements: https://lician.com/financials/fulc
Fulcrum Therapeutics Inc (FULC) market capitalization is $427.0M on the latest cached snapshot.
Fulcrum Therapeutics Inc (FULC) cached previous close $3.75; day range $3.72 – $3.79; volume 1,798,880. Session quote: https://lician.com/quote/fulc
Fulcrum Therapeutics Inc (FULC) latest cached earnings event is "FULC earnings" on Aug 4, 2026. Earnings calendar: https://lician.com/earnings
The latest cached FULC filing is 8-K · Aug 17, 2026. Filings: https://lician.com/sec/fulc